This inventor holds 1 USPTO granted patent. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Cancer Treatment by Tingting He
Introduction
Tingting He is an accomplished inventor based in Chongqing, China. She has made significant contributions to the field of oncology through her innovative research and development of anticancer drugs. Her work focuses on creating effective treatments that minimize adverse reactions and enhance therapeutic outcomes for cancer patients.
Latest Patents
Tingting He holds a patent for an "Intermediate drug with synergistic anticancer activity and polyethylene glycol-coupled synergistic anticancer drug, and preparation method therefor and use thereof." This patent describes an intermediate drug that exhibits synergistic anticancer activity, along with a polyethylene glycol-coupled drug. The invention aims to facilitate the combined medication of various anticancer drugs while avoiding toxic reactions caused by drug interactions. The drugs are designed to overcome multidrug resistance in cancers, providing a synergistic effect that can be utilized in preparing anticancer medicaments.
Career Highlights
Tingting He is associated with Chongqing Upgra Biotechnology Co., Ltd., where she continues to advance her research in cancer treatment. Her dedication to innovation in drug development has positioned her as a key figure in the biotechnology sector.
Collaborations
Tingting collaborates with notable colleagues, including Yanyan Zhang and Maofen Chen, who contribute to her research efforts and the development of new therapeutic strategies.
Conclusion
Tingting He exemplifies the spirit of innovation in the fight against cancer through her groundbreaking work and patent contributions. Her research not only enhances the efficacy of cancer treatments but also aims to improve the quality of life for patients battling this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile